MyFinsight
Home
Blog
About
Contact
algs: the balance sheet
Download
Download image
Total, at cost
$14,490K
Other current assets
$4,229K
Short-term investments
$57,150K
Restricted cash
$110K
Cash and cash
equivalents
$41,946K
Other assets
$713K
Property and equipment,
net
$2,035K
Operating lease
right-of-use assets
$3,581K
Total current assets
$103,435K
Accumulated depreciation
$12,455K
Total assets
$109,764K
Total liabilities and
stockholders' equity...
$109,764K
Total stockholders'
equity (deficit)
$71,833K
Total liabilities
$37,931K
Accumulated deficit
-$622,320K
Accumulated other
comprehensive income
$455K
Additional paid-in capital
$693,689K
Long term liability
$46K
2023 common warrants
liability
$13,396K
Finance lease
liabilities, net of current...
$122K
Operating lease
liabilities, net of current...
$2,380K
Total current
liabilities
$21,987K
Common stock, 0.0001
par value...
$9K
Deferred revenue,
current
$168K
Finance lease
liabilities, current
$21K
Operating lease
liabilities, current
$3,542K
Accrued liabilities
$13,605K
Accounts payable
$4,651K
Back
Back
Balance Sheet
source: myfinsight.com
Aligos Therapeutics, Inc. (ALGS)
Aligos Therapeutics, Inc. (ALGS)